Alvorlige bivirkninger, så som neutropen sepsis (0, 8%) og pneumoni (2, 5%), blev rapporteret hos patienter, der modtog azacitidin.
Serious adverse reactions such as neutropenic sepsis (0.8%) and pneumonia (2.5%) were reported in patients receiving azacitidine.